Peripheral neuropathy, either inherited or acquired, represents a very common disorder for which effective clinical treatments are not available yet. Observations here summarized indicate that neuroactive steroids, such as progesterone, testosterone and their reduced metabolites, might represent a promising therapeutic option. Peripheral nerves are able to synthesize and metabolize neuroactive steroids and are a target for these molecules, since they express classical and non-classical steroid receptors. Neuroactive steroids modulate the expression of key transcription factors for Schwann cell function, regulate Schwann cell proliferation and promote the expression of myelin proteins involved in the maintenance of myelin multilamellar structure, such as myelin protein zero and peripheral myelin protein 22. These actions may result in the protection and regeneration of peripheral nerves affected by different forms of pathological alterations. Indeed, neuroactive steroids are able to counteract biochemical, morphological and functional alterations of peripheral nerves in different experimental models of neuropathy, including the alterations caused by aging, diabetic neuropathy and physical injury. Therefore, neuroactive steroids, pharmacological agents able to increase their local synthesis and synthetic ligands for their receptors have a promising potential for the treatment of different forms of peripheral neuropathy.

Neuroactive steroids and peripheral neuropathy / I. Roglio, S.Giatti, M. Pesaresi, R. Bianchi, G. Cavaletti, G. Lauria, L.M. Garcia-Segura, R.C. Melcangi. - In: BRAIN RESEARCH REVIEWS. - ISSN 0165-0173. - 57:2(2008), pp. 460-469. [10.1016/j.brainresrev.2007.04.010]

Neuroactive steroids and peripheral neuropathy

I. Roglio;S. Giatti;M. Pesaresi;G. Lauria;R.C. Melcangi
2008

Abstract

Peripheral neuropathy, either inherited or acquired, represents a very common disorder for which effective clinical treatments are not available yet. Observations here summarized indicate that neuroactive steroids, such as progesterone, testosterone and their reduced metabolites, might represent a promising therapeutic option. Peripheral nerves are able to synthesize and metabolize neuroactive steroids and are a target for these molecules, since they express classical and non-classical steroid receptors. Neuroactive steroids modulate the expression of key transcription factors for Schwann cell function, regulate Schwann cell proliferation and promote the expression of myelin proteins involved in the maintenance of myelin multilamellar structure, such as myelin protein zero and peripheral myelin protein 22. These actions may result in the protection and regeneration of peripheral nerves affected by different forms of pathological alterations. Indeed, neuroactive steroids are able to counteract biochemical, morphological and functional alterations of peripheral nerves in different experimental models of neuropathy, including the alterations caused by aging, diabetic neuropathy and physical injury. Therefore, neuroactive steroids, pharmacological agents able to increase their local synthesis and synthetic ligands for their receptors have a promising potential for the treatment of different forms of peripheral neuropathy.
5α-reductase; Progesterone; Schwann cells; Sciatic nerve; Testosterone; Tetrahydroprogesterone
Settore MED/13 - Endocrinologia
Settore MED/26 - Neurologia
2008
Article (author)
File in questo prodotto:
File Dimensione Formato  
aaaBrain Res Review_2008.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 428.5 kB
Formato Adobe PDF
428.5 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/45392
Citazioni
  • ???jsp.display-item.citation.pmc??? 19
  • Scopus 77
  • ???jsp.display-item.citation.isi??? 69
social impact